Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/Salmeterol

Summary

The purpose of this study is to demonstrate superiority of Fluticasone/Formoterol (Flutiform®) to Fluticasone/salmeterol based on the small airway function by assessing the Impulse Oscillometic System (IOS) in uncontrolled asthma patients requiring ICS/LABA concomitant treatment.

Timeline

Start

2015-08-31

Primary completion

2017-04-06

Completion

2017-05

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty of patients enrollments”

Drugs

Indications